+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

miRNA Sequencing And Assay Market Size, Share & Trends Analysis Report By Product & Service (Library Preparation Kits), By Technology, By Workflow, By Application, By End-use, By Region, And Segment Forecasts, 2023 - 2030

  • PDF Icon

    Report

  • 120 Pages
  • October 2023
  • Region: Global
  • Grand View Research
  • ID: 5899550
Description Jump to:
The global miRNA sequencing and assay market size is expected to reach USD 823.5 Million by 2030, registering a CAGR of 13.3% from 2023 to 2030. For instance, various research studies stated that miRNAs can be efficiently used as biomarkers in the prognosis and diagnosis of cancer (cervical, ovarian, and breast), sepsis, cardiovascular diseases, and nervous system conditions. Thus, miRNA sequence analysis is significantly employed for gene regulation analysis in clinical disorders. For instance, an article published in frontiers, in March 2022, stated that blood-based miRNA biomarkers could be used to correlate brain-based miRNA expression.

The COVID-19 pandemic has enhanced the usage of miRNA to identify the presence of coronavirus. miRNA biomarkers have potential application to indicate and diagnose the COVID-19 severity. It plays a significant role in immune response, viral proliferation, replication of infected cells, and cardiovascular dysfunction. In addition, plasma recovered from COVID-19 patients is rich in antibodies and antiviral miRNAs. It has been utilized to treat COVID-19-infected patients. This has resulted in increasing research studies that focus on the miRNA sequence analysis from the patient as well as the virus.

Prominent players such as PerkinElmer Inc.; Illumina, Inc.; and Qiagen offer innovative sequencing products for several clinical applications. Furthermore, these companies have entered into several strategic initiatives with research institutes to expand the sequencing application in research studies. For instance, in January 2022, BIORCHESTRA, a South Korean biopharmaceutical company, entered into a partnership agreement with SK Biopharmaceuticals to accelerate research and development into novel therapeutic compounds that target miRNAs.

Key market players are involved in the development of new tools, instruments, and kits with high specificity and reproducibility, which is fueling the market growth. For instance, in October 2019, TriLink BioTechnologies introduced two primer sets for its CleanTag kit. Thermo Fisher Scientific's sequencer platform can prepare small RNA libraries using these new Ion Torrent Convert barcode primer sets. Such launches are expected to boost market growth.

miRNA Sequencing And Assay Market Report Highlights

  • The products segment dominated the market with the largest revenue share of around 80% in 2022. This is due to the presence of several key companies that offer a broad range of consumables, kits, and instruments for specific applications
  • By technology, the sequencing by synthesis segment dominated the market with the largest revenue share of over 32% in 2022. This is due to its fast turnaround time, high sensitivity, and high throughput. Moreover, it plays a key role in the mutation detection of tumor tissue, which helps to develop personalized therapies
  • By workflow, the sequencing segment dominated the market with the largest revenue share of over 50% in 2022 and is expected to grow at the fastest CAGR of 14.1% over the forecast period as it is the most important step in the workflow. It has become a key research tool in biological research and several disease diagnoses
  • By application, the cancer segment dominated the market and accounted for the largest revenue share of over 35% in 2022. Several ongoing research in cancer using miRNA as a biomarker to study the prognosis and diagnosis of cancer to develop new therapies is contributing to the segment growth
  • By end-use, the research and academic institutes segment dominated the market and accounted for the largest revenue share of over 50% in 2022. The growth is attributed to the increased R&D studies conducted by academic institutes using miRNA sequencing techniques
  • Asia Pacific is expected to grow at the fastest CAGR of 15.4% during the forecast period. This is due to the growing healthcare infrastructure, significant targeted population, and high unmet clinical needs


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Product & Service
1.1.2. Technology
1.1.3. Workflow
1.1.4. Application
1.1.5. End use
1.1.6. Regional scope
1.1.7. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product & service outlook
2.2.2. Technology outlook
2.2.3. Workflow outlook
2.2.4. Application outlook
2.2.5. End use outlook
2.2.6. Regional outlook
2.3. Competitive Insights
Chapter 3. miRNA Sequencing And Assay Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market driver analysis
3.3.2. Market restraint analysis
3.4. miRNA Sequencing And Assay Market Analysis Tools
3.4.1. Industry Analysis - Porter’s
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Technological landscape
3.4.2.3. Economic landscape
Chapter 4. miRNA Sequencing And Assay: Product & Service Estimates & Trend Analysis
4.1. miRNA Sequencing And Assay Market: Key Takeaways
4.2. miRNA Sequencing And Assay Market: Movement & Market Share Analysis, 2022 & 2030
4.3. Products
4.3.1. Products market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.2. Library preparation kits
4.3.2.1. Library preparation kits market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.3. Sequencing consumables
4.3.3.1. Sequencing consumables market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.4. Instruments
4.3.4.1. Instruments market estimates and forecasts, 2018 to 2030 (USD Million)
4.4. Services
4.4.1. Services market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. MiRNA Sequencing And Assay: Technology Estimates & Trend Analysis
5.1. MiRNA Sequencing And Assay Market: Key Takeaways
5.2. MiRNA Sequencing And Assay Market: Movement & Market Share Analysis, 2022 & 2030
5.3. Sequencing by synthesis
5.3.1. Sequencing by synthesis market estimates and forecasts, 2018 to 2030 (USD Million)
5.4. Sequencing By Oligonucleotide Ligation and Detection (SOLiD)
5.4.1. Sequencing by oligonucleotide ligation and detection (SOLiD) market estimates and forecasts, 2018 to 2030 (USD Million)
5.5. Nanopore Sequencing
5.5.1. Nanopore sequencing market estimates and forecasts, 2018 to 2030 (USD Million)
5.6. Sanger Sequencing
5.6.1. Sanger sequencing market estimates and forecasts, 2018 to 2030 (USD Million)
5.7. Single molecule real - time (SMRT) Sequencing
5.7.1. Single molecule real - time (SMRT) sequencing market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. MiRNA Sequencing And Assay: Workflow Estimates & Trend Analysis
6.1. MiRNA Sequencing And Assay Market: Key Takeaways
6.2. MiRNA Sequencing And Assay Market: Movement & Market Share Analysis, 2022 & 2030
6.3. Library Preparation
6.3.1. Library preparation market estimates and forecasts, 2018 to 2030 (USD Million)
6.4. Sequencing
6.4.1. Sequencing market estimates and forecasts, 2018 to 2030 (USD Million)
6.5. Data analysis & storage
6.5.1. Data analysis & storage market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 7. MiRNA Sequencing And Assay: Application Estimates & Trend Analysis
7.1. MiRNA Sequencing And Assay Market: Key Takeaways
7.2. MiRNA Sequencing And Assay Market: Movement & Market Share Analysis, 2022 & 2030
7.3. Cancer
7.3.1. Cancer market estimates and forecasts, 2018 to 2030 (USD Million)
7.4. Polyglutamine Diseases
7.4.1. Polyglutamine diseases market estimates and forecasts, 2018 to 2030 (USD Million)
7.5. Autoimmune Disease
7.5.1. Autoimmune disease market estimates and forecasts, 2018 to 2030 (USD Million)
7.6. Schizophrenia
7.6.1. Schizophrenia market estimates and forecasts, 2018 to 2030 (USD Million)
7.7. Others
7.7.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 8. MiRNA Sequencing And Assay: End Use Estimates & Trend Analysis
8.1. MiRNA Sequencing And Assay Market: Key Takeaways
8.2. MiRNA Sequencing And Assay Market: Movement & Market Share Analysis, 2022 & 2030
8.3. Pharmaceutical & Biotechnology Industry
8.3.1. Pharmaceutical & biotechnology industry market estimates and forecasts, 2018 to 2030 (USD Million)
8.4. Research & Academic Institutes
8.4.1. Research & academic institutes market estimates and forecasts, 2018 to 2030 (USD Million)
8.5. Others
8.5.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 9. MiRNA Sequencing And Assay: Regional Estimates & Trend Analysis
9.1. Regional Outlook
9.2. MiRNA Sequencing And Assay Market by Region: Key Takeaway
9.3. North America
9.3.1. North America market estimates and forecasts, 2018 - 2030 (USD Million) (Revenue, USD Million)
9.3.2. U.S.
9.3.2.1. U.S. market estimates and forecasts, 2018 - 2030 (USD Million) (Revenue, USD Million)
9.3.3. Canada
9.3.3.1. Canada market estimates and forecasts, 2018 - 2030 (USD Million) (Revenue, USD Million)
9.4. Europe
9.4.1. Europe market estimates and forecasts, 2018 - 2030 (USD Million) (Revenue, USD Million)
9.4.2. UK
9.4.2.1. UK market estimates and forecasts, 2018 - 2030 (USD Million) (Revenue, USD Million)
9.4.3. Germany
9.4.3.1. Germany market estimates and forecasts, 2018 - 2030 (USD Million) (Revenue, USD Million)
9.4.4. France
9.4.4.1. France market estimates and forecasts, 2018 - 2030 (USD Million) (Revenue, USD Million)
9.4.5. Italy
9.4.5.1. Italy market estimates and forecasts, 2018 - 2030 (USD Million) (Revenue, USD Million)
9.4.6. Spain
9.4.6.1. Spain market estimates and forecasts, 2018 - 2030 (USD Million) (Revenue, USD Million)
9.4.7. Sweden
9.4.7.1. Sweden market estimates and forecasts, 2018 - 2030 (USD Million) (Revenue, USD Million)
9.4.8. Norway
9.4.8.1. Norway market estimates and forecasts, 2018 - 2030 (USD Million) (Revenue, USD Million)
9.4.9. Denmark
9.4.9.1. Denmark market estimates and forecasts, 2018 - 2030 (USD Million) (Revenue, USD Million)
9.5. Asia Pacific
9.5.1. Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million) (Revenue, USD Million)
9.5.2. Japan
9.5.2.1. Japan market estimates and forecasts, 2018 - 2030 (USD Million) (Revenue, USD Million)
9.5.3. China
9.5.3.1. China market estimates and forecasts, 2018 - 2030 (USD Million) (Revenue, USD Million)
9.5.4. India
9.5.4.1. India market estimates and forecasts, 2018 - 2030 (USD Million) (Revenue, USD Million)
9.5.5. Australia
9.5.5.1. Australia market estimates and forecasts, 2018 - 2030 (USD Million) (Revenue, USD Million)
9.5.6. Thailand
9.5.6.1. Thailand market estimates and forecasts, 2018 - 2030 (USD Million) (Revenue, USD Million)
9.5.7. South Korea
9.5.7.1. South Korea market estimates and forecasts, 2018 - 2030 (USD Million) (Revenue, USD Million)
9.6. Latin America
9.6.1. Latin America market estimates and forecasts, 2018 - 2030 (USD Million) (Revenue, USD Million)
9.6.2. Brazil
9.6.2.1. Brazil market estimates and forecasts, 2018 - 2030 (USD Million) (Revenue, USD Million)
9.6.3. Mexico
9.6.3.1. Mexico market estimates and forecasts, 2018 - 2030 (USD Million) (Revenue, USD Million)
9.6.4. Argentina
9.6.4.1. Argentina market estimates and forecasts, 2018 - 2030 (USD Million) (Revenue, USD Million)
9.7. MEA
9.7.1. MEA market estimates and forecasts, 2018 - 2030 (USD Million) (Revenue, USD Million)
9.7.2. Saudi Arabia
9.7.2.1. Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million) (Revenue, USD Million)
9.7.3. South Africa
9.7.3.1. South Africa market estimates and forecasts, 2018 - 2030 (USD Million) (Revenue, USD Million)
9.7.4. UAE
9.7.4.1. UAE market estimates and forecasts, 2018 - 2030 (USD Million) (Revenue, USD Million)
9.7.5. Kuwait
9.7.5.1. Kuwait market estimates and forecasts, 2018 - 2030 (USD Million) (Revenue, USD Million)
Chapter 10. Competitive Landscape
10.1. Recent Developments & Impact Analysis, By Key Market Participants
10.2. Market Participant Categorization
10.2.1. Thermo Fisher Scientific, Inc.
10.2.1.1. Company overview
10.2.1.2. Financial performance
10.2.1.3. Product benchmarking
10.2.1.4. Strategic initiatives
10.2.2. Illumina, Inc.
10.2.2.1. Company overview
10.2.2.2. Financial performance
10.2.2.3. Product benchmarking
10.2.2.4. Strategic initiatives
10.2.3. QIAGEN
10.2.3.1. Company overview
10.2.3.2. Financial performance
10.2.3.3. Product benchmarking
10.2.3.4. Strategic initiatives
10.2.4. PerkinElmer, Inc
10.2.4.1. Company overview
10.2.4.2. Financial performance
10.2.4.3. Product benchmarking
10.2.4.4. Strategic initiatives
10.2.5. Abcam plc
10.2.5.1. Company overview
10.2.5.2. Financial performance
10.2.5.3. Product benchmarking
10.2.5.4. Strategic initiatives
10.2.6. New England Biolabs
10.2.6.1. Company overview
10.2.6.2. Financial performance
10.2.6.3. Product benchmarking
10.2.6.4. Strategic initiatives
10.2.7. Takara Bio Inc.
10.2.7.1. Company overview
10.2.7.2. Financial performance
10.2.7.3. Product benchmarking
10.2.7.4. Strategic initiatives
10.2.8. Lexogen GmbH
10.2.8.1. Company overview
10.2.8.2. Financial performance
10.2.8.3. Product benchmarking
10.2.8.4. Strategic initiatives
10.2.9. Norgen Biotek Corp.
10.2.9.1. Company overview
10.2.9.2. Financial performance
10.2.9.3. Product benchmarking
10.2.9.4. Strategic initiatives
10.2.10. Maravai LifeSciences
10.2.10.1. Company overview
10.2.10.2. Financial performance
10.2.10.3. Product benchmarking
10.2.10.4. Strategic initiatives
10.2.11. HTG Molecular Diagnostics, Inc.
10.2.11.1. Company overview
10.2.11.2. Financial performance
10.2.11.3. Product benchmarking
10.2.11.4. Strategic initiatives
10.2.12. Meridian Bioscience, Inc.
10.2.12.1. Company overview
10.2.12.2. Financial performance
10.2.12.3. Product benchmarking
10.2.12.4. Strategic initiatives
10.2.13. System Biosciences, LLC
10.2.13.1. Company overview
10.2.13.2. Financial performance
10.2.13.3. Product benchmarking
10.2.13.4. Strategic initiatives
List of Tables
Table 1 List of abbreviations
Table 2 North America miRNA sequencing and assay market, by product & service, 2018-2030 (USD Million)
Table 3 North America miRNA sequencing and assay market, by technology, 2018-2030 (USD Million)
Table 4 North America miRNA sequencing and assay market, by workflow, 2018-2030 (USD Million)
Table 5 North America miRNA sequencing and assay market, by application, 2018-2030 (USD Million)
Table 6 North America miRNA sequencing and assay market, by end use, 2018-2030 (USD Million)
Table 7 North America miRNA sequencing and assay market, by region, 2018-2030 (USD Million)
Table 8 U.S. miRNA sequencing and assay market, by product & service, 2018-2030 (USD Million)
Table 9 U.S. miRNA sequencing and assay market, by technology, 2018-2030 (USD Million)
Table 10 U.S. miRNA sequencing and assay market, by workflow, 2018-2030 (USD Million)
Table 11 U.S. miRNA sequencing and assay market, by application, 2018-2030 (USD Million)
Table 12 U.S. miRNA sequencing and assay market, by end use, 2018-2030 (USD Million)
Table 13 Canada miRNA sequencing and assay market, by product & service, 2018-2030 (USD Million)
Table 14 Canada miRNA sequencing and assay market, by technology, 2018-2030 (USD Million)
Table 15 Canada miRNA sequencing and assay market, by workflow, 2018-2030 (USD Million)
Table 16 Canada miRNA sequencing and assay market, by application, 2018-2030 (USD Million)
Table 17 Canada miRNA sequencing and assay market, by end use, 2018-2030 (USD Million)
Table 18 Europe miRNA sequencing and assay market, by product & service, 2018-2030 (USD Million)
Table 19 Europe miRNA sequencing and assay market, by technology, 2018-2030 (USD Million)
Table 20 Europe miRNA sequencing and assay market, by workflow, 2018-2030 (USD Million)
Table 21 Europe miRNA sequencing and assay market, by application, 2018-2030 (USD Million)
Table 22 Europe miRNA sequencing and assay market, by end use, 2018-2030 (USD Million)
Table 23 Europe miRNA sequencing and assay market, by region, 2018-2030 (USD Million)
Table 24 Germany miRNA sequencing and assay market, by product & service, 2018-2030 (USD Million)
Table 25 Germany miRNA sequencing and assay market, by technology, 2018-2030 (USD Million)
Table 26 Germany miRNA sequencing and assay market, by workflow, 2018-2030 (USD Million)
Table 27 Germany miRNA sequencing and assay market, by application, 2018-2030 (USD Million)
Table 28 Germany miRNA sequencing and assay market, by end use, 2018-2030 (USD Million)
Table 29 UK miRNA sequencing and assay market, by product & service, 2018-2030 (USD Million)
Table 30 UK miRNA sequencing and assay market, by technology, 2018-2030 (USD Million)
Table 31 UK miRNA sequencing and assay market, by workflow, 2018-2030 (USD Million)
Table 32 UK miRNA sequencing and assay market, by application, 2018-2030 (USD Million)
Table 33 UK miRNA sequencing and assay market, by end use, 2018-2030 (USD Million)
Table 34 France miRNA sequencing and assay market, by product & service, 2018-2030 (USD Million)
Table 35 France miRNA sequencing and assay market, by technology, 2018-2030 (USD Million)
Table 36 France miRNA sequencing and assay market, by workflow, 2018-2030 (USD Million)
Table 37 France miRNA sequencing and assay market, by application, 2018-2030 (USD Million)
Table 38 France miRNA sequencing and assay market, by end use, 2018-2030 (USD Million)
Table 39 Italy miRNA sequencing and assay market, by product & service, 2018-2030 (USD Million)
Table 40 Italy miRNA sequencing and assay market, by technology, 2018-2030 (USD Million)
Table 41 Italy miRNA sequencing and assay market, by workflow, 2018-2030 (USD Million)
Table 42 Italy miRNA sequencing and assay market, by application, 2018-2030 (USD Million)
Table 43 Italy miRNA sequencing and assay market, by end use, 2018-2030 (USD Million)
Table 44 Spain miRNA sequencing and assay market, by product & service, 2018-2030 (USD Million)
Table 45 Spain miRNA sequencing and assay market, by technology, 2018-2030 (USD Million)
Table 46 Spain miRNA sequencing and assay market, by workflow, 2018-2030 (USD Million)
Table 47 Spain miRNA sequencing and assay market, by application, 2018-2030 (USD Million)
Table 48 Spain miRNA sequencing and assay market, by end use, 2018-2030 (USD Million)
Table 49 Sweden miRNA sequencing and assay market, by product & service, 2018-2030 (USD Million)
Table 50 Sweden miRNA sequencing and assay market, by technology, 2018-2030 (USD Million)
Table 51 Sweden miRNA sequencing and assay market, by workflow, 2018-2030 (USD Million)
Table 52 Sweden miRNA sequencing and assay market, by application, 2018-2030 (USD Million)
Table 53 Sweden miRNA sequencing and assay market, by end use, 2018-2030 (USD Million)
Table 54 Norway miRNA sequencing and assay market, by product & service, 2018-2030 (USD Million)
Table 55 Norway miRNA sequencing and assay market, by technology, 2018-2030 (USD Million)
Table 56 Norway miRNA sequencing and assay market, by workflow, 2018-2030 (USD Million)
Table 57 Norway miRNA sequencing and assay market, by application, 2018-2030 (USD Million)
Table 58 Norway miRNA sequencing and assay market, by end use, 2018-2030 (USD Million)
Table 59 Denmark miRNA sequencing and assay market, by product & service, 2018-2030 (USD Million)
Table 60 Denmark miRNA sequencing and assay market, by technology, 2018-2030 (USD Million)
Table 61 Denmark miRNA sequencing and assay market, by workflow, 2018-2030 (USD Million)
Table 62 Denmark miRNA sequencing and assay market, by application, 2018-2030 (USD Million)
Table 63 Denmark miRNA sequencing and assay market, by end use, 2018-2030 (USD Million)
Table 64 Asia Pacific miRNA sequencing and assay market, by product & service, 2018-2030 (USD Million)
Table 65 Asia Pacific miRNA sequencing and assay market, by technology, 2018-2030 (USD Million)
Table 66 Asia Pacific miRNA sequencing and assay market, by workflow, 2018-2030 (USD Million)
Table 67 Asia Pacific miRNA sequencing and assay market, by application, 2018-2030 (USD Million)
Table 68 Asia Pacific miRNA sequencing and assay market, by end use, 2018-2030 (USD Million)
Table 69 Asia Pacific miRNA sequencing and assay market, by region, 2018-2030 (USD Million)
Table 70 China miRNA sequencing and assay market, by product & service, 2018-2030 (USD Million)
Table 71 China miRNA sequencing and assay market, by technology, 2018-2030 (USD Million)
Table 72 China miRNA sequencing and assay market, by workflow, 2018-2030 (USD Million)
Table 73 China miRNA sequencing and assay market, by application, 2018-2030 (USD Million)
Table 74 China miRNA sequencing and assay market, by end use, 2018-2030 (USD Million)
Table 75 Japan miRNA sequencing and assay market, by product & service, 2018-2030 (USD Million)
Table 76 Japan miRNA sequencing and assay market, by technology, 2018-2030 (USD Million)
Table 77 Japan miRNA sequencing and assay market, by workflow, 2018-2030 (USD Million)
Table 78 Japan miRNA sequencing and assay market, by application, 2018-2030 (USD Million)
Table 79 Japan miRNA sequencing and assay market, by end use, 2018-2030 (USD Million)
Table 80 India miRNA sequencing and assay market, by product & service, 2018-2030 (USD Million)
Table 81 India miRNA sequencing and assay market, by technology, 2018-2030 (USD Million)
Table 82 India miRNA sequencing and assay market, by workflow, 2018-2030 (USD Million)
Table 83 India miRNA sequencing and assay market, by application, 2018-2030 (USD Million)
Table 84 India miRNA sequencing and assay market, by end use, 2018-2030 (USD Million)
Table 85 Australia miRNA sequencing and assay market, by product & service, 2018-2030 (USD Million)
Table 86 Australia miRNA sequencing and assay market, by technology, 2018-2030 (USD Million)
Table 87 Australia miRNA sequencing and assay market, by workflow, 2018-2030 (USD Million)
Table 88 Australia miRNA sequencing and assay market, by application, 2018-2030 (USD Million)
Table 89 Australia miRNA sequencing and assay market, by end use, 2018-2030 (USD Million)
Table 90 Thailand miRNA sequencing and assay market, by product & service, 2018-2030 (USD Million)
Table 91 Thailand miRNA sequencing and assay market, by technology, 2018-2030 (USD Million)
Table 92 Thailand miRNA sequencing and assay market, by workflow, 2018-2030 (USD Million)
Table 93 Thailand miRNA sequencing and assay market, by application, 2018-2030 (USD Million)
Table 94 Thailand miRNA sequencing and assay market, by end use, 2018-2030 (USD Million)
Table 95 South Korea miRNA sequencing and assay market, by product & service, 2018-2030 (USD Million)
Table 96 South Korea miRNA sequencing and assay market, by technology, 2018-2030 (USD Million)
Table 97 South Korea miRNA sequencing and assay market, by workflow, 2018-2030 (USD Million)
Table 98 South Korea miRNA sequencing and assay market, by application, 2018-2030 (USD Million)
Table 99 South Korea miRNA sequencing and assay market, by end use, 2018-2030 (USD Million)
Table 100 Latin America miRNA sequencing and assay market, by product & service, 2018-2030 (USD Million)
Table 101 Latin America miRNA sequencing and assay market, by technology, 2018-2030 (USD Million)
Table 102 Latin America miRNA sequencing and assay market, by workflow, 2018-2030 (USD Million)
Table 103 Latin America miRNA sequencing and assay market, by application, 2018-2030 (USD Million)
Table 104 Latin America miRNA sequencing and assay market, by end use, 2018-2030 (USD Million)
Table 105 Latin America miRNA sequencing and assay market, by region, 2018-2030 (USD Million)
Table 106 Brazil miRNA sequencing and assay market, by product & service, 2018-2030 (USD Million)
Table 107 Brazil miRNA sequencing and assay market, by technology, 2018-2030 (USD Million)
Table 108 Brazil miRNA sequencing and assay market, by workflow, 2018-2030 (USD Million)
Table 109 Brazil miRNA sequencing and assay market, by application, 2018-2030 (USD Million)
Table 110 Brazil miRNA sequencing and assay market, by end use, 2018-2030 (USD Million)
Table 111 Mexico miRNA sequencing and assay market, by product & service, 2018-2030 (USD Million)
Table 112 Mexico miRNA sequencing and assay market, by technology, 2018-2030 (USD Million)
Table 113 Mexico miRNA sequencing and assay market, by workflow, 2018-2030 (USD Million)
Table 114 Mexico miRNA sequencing and assay market, by application, 2018-2030 (USD Million)
Table 115 Mexico miRNA sequencing and assay market, by end use, 2018-2030 (USD Million)
Table 116 Argentina miRNA sequencing and assay market, by product & service, 2018-2030 (USD Million)
Table 117 Argentina miRNA sequencing and assay market, by technology, 2018-2030 (USD Million)
Table 118 Argentina miRNA sequencing and assay market, by workflow, 2018-2030 (USD Million)
Table 119 Argentina miRNA sequencing and assay market, by application, 2018-2030 (USD Million)
Table 120 Argentina miRNA sequencing and assay market, by end use, 2018-2030 (USD Million)
Table 121 Middle East and Africa miRNA sequencing and assay market, by product & service, 2018-2030 (USD Million)
Table 122 Middle East and Africa miRNA sequencing and assay market, by technology, 2018-2030 (USD Million)
Table 123 Middle East and Africa miRNA sequencing and assay market, by workflow, 2018-2030 (USD Million)
Table 124 Middle East and Africa miRNA sequencing and assay market, by application, 2018-2030 (USD Million)
Table 125 Middle East and Africa miRNA sequencing and assay market, by end use, 2018-2030 (USD Million)
Table 126 Middle East and Africa miRNA sequencing and assay market, by region, 2018-2030 (USD Million)
Table 127 South Africa miRNA sequencing and assay market, by product & service, 2018-2030 (USD Million)
Table 128 South Africa miRNA sequencing and assay market, by technology, 2018-2030 (USD Million)
Table 129 South Africa miRNA sequencing and assay market, by workflow, 2018-2030 (USD Million)
Table 130 South Africa miRNA sequencing and assay market, by application, 2018-2030 (USD Million)
Table 131 South Africa miRNA sequencing and assay market, by end use, 2018-2030 (USD Million)
Table 132 Saudi Arabia miRNA sequencing and assay market, by product & service, 2018-2030 (USD Million)
Table 133 Saudi Arabia miRNA sequencing and assay market, by technology, 2018-2030 (USD Million)
Table 134 Saudi Arabia miRNA sequencing and assay market, by workflow, 2018-2030 (USD Million)
Table 135 Saudi Arabia miRNA sequencing and assay market, by application, 2018-2030 (USD Million)
Table 136 Saudi Arabia miRNA sequencing and assay market, by end use, 2018-2030 (USD Million)
Table 137 UAE miRNA sequencing and assay market, by product & service, 2018-2030 (USD Million)
Table 138 UAE miRNA sequencing and assay market, by technology, 2018-2030 (USD Million)
Table 139 UAE miRNA sequencing and assay market, by workflow, 2018-2030 (USD Million)
Table 140 UAE miRNA sequencing and assay market, by application, 2018-2030 (USD Million)
Table 141 UAE miRNA sequencing and assay market, by end use, 2018-2030 (USD Million)
Table 142 Kuwait miRNA sequencing and assay market, by product & service, 2018-2030 (USD Million)
Table 143 Kuwait miRNA sequencing and assay market, by technology, 2018-2030 (USD Million)
Table 144 Kuwait miRNA sequencing and assay market, by workflow, 2018-2030 (USD Million)
Table 145 Kuwait miRNA sequencing and assay market, by application, 2018-2030 (USD Million)
Table 146 Kuwait miRNA sequencing and assay market, by end use, 2018-2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 MiRNA sequencing and assay: Market outlook
Fig. 9 MiRNA sequencing and assay: Competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 MiRNA sequencing and assay market driver impact
Fig. 14 MiRNA sequencing and assay market restraint impact
Fig. 15 MiRNA sequencing and assay market strategic initiatives analysis
Fig. 16 MiRNA sequencing and assay market: Product & service movement analysis
Fig. 17 MiRNA sequencing and assay market: Product & service outlook and key takeaways
Fig. 18 Products market estimates and forecasts, 2018-2030 (USD Million)
Fig. 19 Library preparation kits market estimates and forecasts, 2018-2030 (USD Million)
Fig. 20 Sequencing consumables market estimates and forecasts, 2018-2030 (USD Million)
Fig. 21 Instruments market estimates and forecasts, 2018-2030 (USD Million)
Fig. 22 Services market estimates and forecasts, 2018-2030 (USD Million)
Fig. 23 MiRNA sequencing and assay market: Technology movement analysis
Fig. 24 MiRNA sequencing and assay market: Technology outlook and key takeaways
Fig. 25 Sequencing by synthesis market estimates and forecasts, 2018-2030 (USD Million)
Fig. 26 Sequencing by oligonucleotide ligation and detection (solid) market estimates and forecasts, 2018-2030 (USD Million)
Fig. 27 Nanopore sequencing market estimates and forecasts, 2018-2030 (USD Million)
Fig. 28 Sanger sequencing market estimates and forecasts, 2018-2030 (USD Million)
Fig. 29 Single molecule real-time (SMRT) sequencing market estimates and forecasts, 2018-2030 (USD Million)
Fig. 30 MiRNA sequencing and assay market: Workflow movement analysis
Fig. 31 MiRNA sequencing and assay market: Workflow outlook and key takeaways
Fig. 32 Library preparation market estimates and forecasts, 2018-2030 (USD Million)
Fig. 33 Sequencing market estimates and forecasts, 2018-2030 (USD Million)
Fig. 34 Data analysis & storage market estimates and forecasts, 2018-2030 (USD Million)
Fig. 35 MiRNA sequencing and assay market: Application movement analysis
Fig. 36 MiRNA sequencing and assay market: Application outlook and key takeaways
Fig. 37 Cancer market estimates and forecasts, 2018-2030 (USD Million)
Fig. 38 Polyglutamine diseases market estimates and forecasts, 2018-2030 (USD Million)
Fig. 39 Autoimmune diseases market estimates and forecasts, 2018-2030 (USD Million)
Fig. 40 Schizophrenia market estimates and forecasts, 2018-2030 (USD Million)
Fig. 41 Others market estimates and forecasts, 2018-2030 (USD Million)
Fig. 42 MiRNA sequencing and assay market: End use movement analysis
Fig. 43 MiRNA sequencing and assay market: End use outlook and key takeaways
Fig. 44 Pharmaceutical & biotechnology industry market estimates and forecasts, 2018-2030 (USD Million)
Fig. 45 Research and academic institutes market estimates and forecasts, 2018-2030 (USD Million)
Fig. 46 Others market estimates and forecasts, 2018-2030 (USD Million)
Fig. 47 Global MiRNA sequencing and assay market: Regional movement analysis
Fig. 48 Global MiRNA sequencing and assay market: Regional outlook and key takeaways
Fig. 49 North America market estimates and forecasts, 2018-2030 (USD Million)
Fig. 50 U.S. market estimates and forecasts, 2018-2030 (USD Million)
Fig. 51 Canada market estimates and forecasts, 2018-2030 (USD Million)
Fig. 52 Europe market estimates and forecasts, 2018-2030 (USD Million)
Fig. 53 UK market estimates and forecasts, 2018-2030 (USD Million)
Fig. 54 Germany market estimates and forecasts, 2018-2030 (USD Million)
Fig. 55 France market estimates and forecasts, 2018-2030 (USD Million)
Fig. 56 Italy market estimates and forecasts, 2018-2030 (USD Million)
Fig. 57 Spain market estimates and forecasts, 2018-2030 (USD Million)
Fig. 58 Sweden market estimates and forecasts, 2018-2030 (USD Million)
Fig. 59 Norway market estimates and forecasts, 2018-2030 (USD Million)
Fig. 60 Denmark market estimates and forecasts, 2018-2030 (USD Million)
Fig. 61 Asia Pacific market estimates and forecasts, 2018-2030 (USD Million)
Fig. 62 Japan market estimates and forecasts, 2018-2030 (USD Million)
Fig. 63 China market estimates and forecasts, 2018-2030 (USD Million)
Fig. 64 India market estimates and forecasts, 2018-2030 (USD Million)
Fig. 65 Australia market estimates and forecasts, 2018-2030 (USD Million)
Fig. 66 Thailand market estimates and forecasts, 2018-2030 (USD Million)
Fig. 67 South Korea market estimates and forecasts, 2018-2030 (USD Million)
Fig. 68 Latin America market estimates and forecasts, 2018-2030 (USD Million)
Fig. 69 Brazil market estimates and forecasts, 2018-2030 (USD Million)
Fig. 70 Mexico market estimates and forecasts, 2018-2030 (USD Million)
Fig. 71 Argentina market estimates and forecasts, 2018-2030 (USD Million)
Fig. 72 Middle East and Africa. market estimates and forecasts, 2018-2030 (USD Million)
Fig. 73 Saudi Arabia market estimates and forecasts, 2018-2030 (USD Million)
Fig. 74 South Africa market estimates and forecasts, 2018-2030 (USD Million)
Fig. 75 UAE market estimates and forecasts, 2018-2030 (USD Million)
Fig. 76 Kuwait market estimates and forecasts, 2018-2030 (USD Million)

Companies Mentioned

  • Thermo Fisher Scientific, Inc.
  • Illumina, Inc.
  • QIAGEN
  • PerkinElmer, Inc
  • Abcam plc
  • New England Biolabs
  • Takara Bio Inc.
  • Lexogen GmbH
  • Norgen Biotek Corp.
  • Maravai LifeSciences
  • HTG Molecular Diagnostics, Inc.
  • Meridian Bioscience, Inc.
  • System Biosciences, LLC

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages120
PublishedOctober 2023
Forecast Period2022 - 2030
Estimated Market Value ( USD ) in 2022 $ 304.3 Million
Forecasted Market Value ( USD ) by 2030 $ 823.5 Million
Compound Annual Growth Rate13.3%
Regions CoveredGlobal
No. of Companies Mentioned13

Related Topics

Related Reports

miRNA Sequencing And Assay Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2023 To 2031 - Product Image

miRNA Sequencing And Assay Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2023 To 2031

  • Report
  • 117 Pages
  • Global
From
Global miRNA Sequencing & Assay Market by Product & Service (Products, Services), Technology (Nanopore Sequencing, Sanger Sequencing, Sequencing By Oligonucleotide Ligation & Detection), Workflow, End-User, Application - Forecast 2024-2030 - Product Image

Global miRNA Sequencing & Assay Market by Product & Service (Products, Services), Technology (Nanopore Sequencing, Sanger Sequencing, Sequencing By Oligonucleotide Ligation & Detection), Workflow, End-User, Application - Forecast 2024-2030

  • Report
  • 197 Pages
  • Global
From
miRNA Sequencing and Assay Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Image

miRNA Sequencing and Assay Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • 250 Pages
  • Global
MiRNA Sequencing and Assay Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F - Product Image

MiRNA Sequencing and Assay Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

  • Report
  • 185 Pages
  • Global
From
MicroRNA Research Tools, Diagnostics and Therapeutics: Global Markets - Product Image

MicroRNA Research Tools, Diagnostics and Therapeutics: Global Markets

  • Report
  • 200 Pages
  • Global
From

About the miRNA Sequencing Market

The miRNA Sequencing market is a subset of the larger genomics market. It is focused on the sequencing of microRNAs, which are small, non-coding RNA molecules that regulate gene expression. miRNA sequencing is used to identify and quantify miRNAs in a sample, and can be used to study gene expression, disease diagnosis, and drug development. miRNA sequencing is a rapidly growing field, with a variety of companies offering services and products. These include Illumina, Thermo Fisher Scientific, Agilent Technologies, Bio-Rad Laboratories, and QIAGEN. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.